Earlier this week, we learned that the 2019 Frost & Sullivan North America New Product Innovation Award was given out to Ossio, Inc. for their development of OSSIOfiberTMIntelligent Bone Regeneration Technology. Their innovation is a bone regeneration technology that could shape how future foot and ankle surgeries are performed.
They developed what they claim to be the first fully bio-integrative fixation device that goes above and beyond traditional fixation hardware. The technology uses a fiber architecture that is twice as strong as traditional non-metal fixation devices, but here’s the real kicker. The fiber naturally incorporates into the bone in as little as 18 months, meaning there is no need for a secondary surgery to remove the hardware after the bone has healed.
“OSSIO’s bone regeneration fixation platform is a one-of-a-kind solution that integrates technology and innovation to improve patient quality of life,” said Sowmya Rajagopalan, Global Program Director at Frost & Sullivan. “OSSIOfiberTM is the first fully bio-integrative fixation device that does not compromise quality, as it uses a fiber architecture that is initially twice as strong as traditional non-metal materials typically used within fixation devices and it incorporates naturally into the bone over time, eliminating the need for hardware removal surgery. OSSIO is at the sweet spot of innovative orthopedic design and its unique implant material offers a myriad of opportunities for the global fixation market.”
Surgical Gamechanger
The technology has received 510(k) market clearance from the United States Food and Drug Administration and they began launching the product for foot and ankle fixations just last month. They expect to have a full launch throughout the US by the third quarter of this year.
Researchers believe that the fiber technology can help address foot and ankle fractures, and they hope to expand to other types of fractures that occur during sporting activities, car accidents and high energy traumas. They also want to grow into the reconstruction, pediatrics and spinal segmentation markets in the next few years.
This is such a unique product, as this is the first material that integrates into bone and is completely remodeled after 18 months. I’m very excited to see where this corporation takes the product in the future. They are finally making hardware removal surgery a thing of the past, which will only serve to help patients.
Disclosure: Dr. Silverman works as an independent consultation for Ossio, Inc.
